New research identifies breast cancer patients likely to respond to tamoxifen

by

Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy.… Continue reading →